title: Prediction of long-term outcome by the extent of existing ST-segment deviation in a single electrocardiographic lead shortly after thrombolysis in acute myocardial infarction.
authors.affiliation: Frankenklinik, Bad Neustadt/Saale, Germany. Profschroe@aol.com
authors.forename: Klaus
authors.initials: K
authors.lastname: Schröder
authors.forename: Karl
authors.initials: K
authors.lastname: Wegscheider
authors.forename: Uwe
authors.initials: U
authors.lastname: Zeymer
authors.forename: Rolf
authors.initials: R
authors.lastname: Schröder
mesh_terms: D000368:Aged; D016903:Drug Monitoring / Q000379:methods / Q000592:standards; D004562:Electrocardiography / Q000379:methods* / Q000592:standards; D005260:Female; D005343:Fibrinolytic Agents / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000175:diagnosis* / Q000188:drug therapy* / Q000401:mortality; D018579:Patient Selection; D019095:Point-of-Care Systems; D011237:Predictive Value of Tests; D011379:Prognosis; D016016:Proportional Hazards Models; D011446:Prospective Studies; D011994:Recombinant Proteins / Q000494:pharmacology / Q000627:therapeutic use; D012307:Risk Factors; D013300:Streptokinase / Q000494:pharmacology / Q000627:therapeutic use; D016019:Survival Analysis; D013997:Time Factors; D010959:Tissue Plasminogen Activator / Q000494:pharmacology / Q000627:therapeutic use; D016896:Treatment Outcome
chemical_list: D005343:Fibrinolytic Agents; D011994:Recombinant Proteins; C087896:reteplase; D013300:Streptokinase; D010959:Tissue Plasminogen Activator